Business Context and Reporting Period
This Form 8-K is filed by Helius Medical Technologies, Inc. (not Solana Co) on June 23, 2025. The report addresses the Company's compliance status with Nasdaq Listing Rule 5550(b)(1) regarding minimum stockholders' equity requirements following a public offering.
Key Financial Metrics
- Stockholders' Equity: As of June 17, 2025, the Company reports stockholders' equity of at least $2.5 million, meeting the Nasdaq minimum threshold.
- Recent Capital Raise: On June 6, 2025, the Company completed a public offering with net proceeds of approximately $8.1 million.
- Previous Deficiency: As of December 31, 2024, stockholders' equity had fallen below the $2.5 million requirement.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, or debt levels.
Material Changes
The primary material change is the restoration of stockholders' equity from below the $2.5 million threshold (as of Q4 2024) to at least $2.5 million (as of June 17, 2025) due to the June 6, 2025 public offering. This change is intended to resolve the delisting notice received on March 31, 2025.
Outlook, Risks, and Management Commentary
- Compliance Status: The Company believes it satisfies the Stockholders' Equity Requirement based on the unaudited interim balance sheet attached as Exhibit 99.1.
- Regulatory Risk: The Company is awaiting formal confirmation from Nasdaq that it has evidenced compliance with the Stockholders' Equity Rule and all other criteria for continued listing on The Nasdaq Capital Market.
- Timeline: Nasdaq had previously granted an extension until June 30, 2025, to regain compliance.
Investor Verification Checklist
- Verify the formal confirmation of continued listing status from Nasdaq.
- Review the attached Exhibit 99.1 (Unaudited Interim Consolidated Balance Sheet as of June 17, 2025) to confirm the exact equity figure.
- Confirm the final use of the $8.1 million in net proceeds from the June 6 offering.
- Monitor for any further communications regarding alternative compliance standards if equity levels fluctuate.